• Share of pharma in merchandise exports grew to almost 7 per cent in 2024-25

• PLI schemes, digital adoption, etc to transition India from generic powerhouse to innovation-driven hub: Experts

• Operational realities & global strategy realignment force MNCs to scale back their units in India: Dr Shenoy

• Indian pharma bets big on integrated quality ecosystems to boost audit readiness and operational resilience